Carbamazepine Capsule, Extended Release
Product Images NDC 70518-4492

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-4492). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Carbamazepine 300mg 70518 4492 01)

This is a description of a Carbamazepine Capsule in extended-release form. The capsule is 300 mg and should be swallowed whole without crushing or chewing. The color of the capsule is white and green. It is repackaged by RemedyRepack Inc. in Indiana, PA. The medication is manufactured by Apotex Corp. in Weston, FL. It is recommended to keep this medication out of the reach of children and store it at 20-25°C (68-77°F), with excursions permitted to 15-30°C (59-86°F).*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Carbamazepine Capsules in 300mg extended-release form. The medication should be swallowed whole and not crushed or chewed. The capsules are white and green in color. The usual dosage instructions can be found in the insert. The product is repackaged by RemedyRepack Inc. and manufactured by Apotex Corp. It is important to keep this medication out of reach of children and store it at 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F).*

FDA Label Image

Carbamazepine-figure-1 (Carbamazepine Figure 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.